• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

New-generation antiseizure medications are better tolerated for patients with epilepsy

byPaary BalakumarandAlex Chan
July 16, 2025
in Chronic Disease, Neurology, Pharma
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Newer-generation antiseizure medications (ASMs) were better tolerated and more likely to be maintained than older ASMs.

2. Only 23% of patients were referred to epilepsy specialists despite high rates of pharmacoresistance.

Evidence Rating Level: 3 (Average)

This study analyzed antiseizure medication (ASM) prescription patterns in 84 patients with post-traumatic epilepsy (PTE) following severe traumatic brain injury (TBI), using data from a prospectively maintained single-center database (2002–2018). PTE was defined as a seizure >7 days post-injury, with ≥6 months follow-up. Patients were categorized by ASM type—older (e.g., phenytoin) vs. newer (e.g., levetiracetam)—and assessed for pharmacoresistance, neurology referral, and functional outcomes via the Glasgow Outcome Scale (GOS). At PTE onset, 53% were on newer ASM monotherapy, 27% on older ASMs, and 20% on polytherapy. Newer ASM monotherapy was more likely to be maintained (OR 4.6, p=0.02), while older ASMs were associated with treatment changes. Despite 54% of patients trialing ≥2 ASMs, only 23% were referred to epilepsy specialists. Pharmacoresistance, present in 32% by 2 years, was predicted by decompressive hemicraniectomy (OR 6.0) and initial polytherapy (OR 7.2), and correlated with worse GOS scores. These findings support newer ASM use, early monotherapy, and timely epilepsy referrals to improve long-term outcomes in PTE.

Click to read the study in Neurology

Image: PD

RELATED REPORTS

Rate of incident dementia and care needs among older adults with new traumatic brain injury: a population-based cohort study

Traumatic Brain Injury and Risk of Amyotrophic Lateral Sclerosis

Outcomes of Critically Ill Adult Patients With Acute Encephalitis

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: epilepsyneurologypharmacotherapySeizure
Previous Post

#VisualAbstract: Insulin Efsitora is Noninferior to Insulin Glargine in Type 2 Diabetes without Previous Insulin Therapy

Next Post

Risk of dementia increased with gabapentin prescription in back pain patients

RelatedReports

Unpaid caregivers of older adults experience emotional, physical, and financial difficulty
Chronic Disease

Rate of incident dementia and care needs among older adults with new traumatic brain injury: a population-based cohort study

October 17, 2025
Quick Take: Amyotrophic Lateral Sclerosis versus Multifocal Motor Neuropathy: Utility of MR Neurography
Chronic Disease

Traumatic Brain Injury and Risk of Amyotrophic Lateral Sclerosis

October 8, 2025
Brain lesions on MRI linked with subsequent increased stroke risk
Emergency

Outcomes of Critically Ill Adult Patients With Acute Encephalitis

September 25, 2025
Prevalence of hypertension among adolescents varies by race and BMI
Neurology

Early Blood Pressure Targets in Acute Spinal Cord Injury: A Randomized Clinical Trial

September 24, 2025
Next Post
Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine

Risk of dementia increased with gabapentin prescription in back pain patients

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

MLC901 may be effective in treatment of post-concussion symptoms in phase III study

#VisualAbstract: Neoadjuvant and Adjuvant Pembroli-zumab Increased Survival in Locally Advanced Head and Neck Cancer

#VisualAbstract: Neoadjuvant and Adjuvant Pembroli-zumab Increased Survival in Locally Advanced Head and Neck Cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Rate of incident dementia and care needs among older adults with new traumatic brain injury: a population-based cohort study
  • Self-Help App for Depression in People With Intellectual Disabilities: A Randomized Clinical Trial
  • A Hybrid Chatbot to Promote Pneumococcal Vaccination Among Older Adults: A Randomized Clinical Trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.